CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-22 | Mahoney Karen Chief Human Resources Officer | Shares withheld for taxes | −771 | $37.98 | $29K | 1,854 |
| 2025-07-22 | Mahoney Karen Chief Human Resources Officer | Option exercise · Restricted Stock Unit | +2,625 | 7,875 | ||
| 2025-06-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +10,000 | $18.00 | $180K | 76,237 |
| 2025-06-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $40.09 | $401K | 66,237 |
| 2025-06-02 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 18,750 | ||
| 2025-05-15 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +14,063 | $2.65 | $37K | 274,417 |
| 2025-05-15 | Colangelo Dominick President and CEO | Sale 10b5-1 | −14,063 | $41.53 | $584K | 260,354 |
| 2025-05-15 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +14,063 | 0 | ||
| 2025-05-14 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +14,062 | $2.65 | $37K | 274,416 |
| 2025-05-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −14,062 | $42.25 | $594K | 260,354 |
| 2025-05-14 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +14,062 | 14,063 | ||
| 2025-05-07 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +7,000 | $2.76 | $19K | 22,100 |
| 2025-05-07 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $39.98 | $280K | 15,100 |
| 2025-05-07 | MCLAUGHLIN KEVIN F Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +7,000 | 7,000 | ||
| 2025-04-30 | Hagen Heidi Director | Option exercise | +3,200 | 31,850 | ||
| 2025-04-30 | Hagen Heidi Director | Option exercise · Restricted Stock Unit | +3,200 | 0 | ||
| 2025-04-30 | Hagen Heidi Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2025-04-30 | Hagen Heidi Director | Grant or award · Restricted Stock Unit | +3,200 | 3,200 | ||
| 2025-04-30 | MCLAUGHLIN KEVIN F Director | Option exercise | +3,200 | 15,100 | ||
| 2025-04-30 | MCLAUGHLIN KEVIN F Director | Option exercise · Restricted Stock Unit | +3,200 | 0 |
Page 13 of 75 · 1,497 trades